SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-12-460805
Filing Date
2012-11-08
Accepted
2012-11-08 17:18:03
Documents
11
Period of Report
2012-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d398189d10q.htm 10-Q 778432
2 EX-31.1 d398189dex311.htm EX-31.1 8669
3 EX-31.2 d398189dex312.htm EX-31.2 8711
4 EX-32.1 d398189dex321.htm EX-32.1 3549
5 EX-32.2 d398189dex322.htm EX-32.2 3558
  Complete submission text file 0001193125-12-460805.txt   4387883

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT cemp-20120930.xml EX-101.INS 579462
7 XBRL TAXONOMY EXTENSION SCHEMA cemp-20120930.xsd EX-101.SCH 41964
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cemp-20120930_cal.xml EX-101.CAL 51232
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cemp-20120930_def.xml EX-101.DEF 138076
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE cemp-20120930_lab.xml EX-101.LAB 317655
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cemp-20120930_pre.xml EX-101.PRE 239648
Mailing Address 6340 QUADRANGLE DRIVE SUITE 100 CHAPEL HILL NC 27517-8149
Business Address 6340 QUADRANGLE DRIVE SUITE 100 CHAPEL HILL NC 27517-8149 919-313-6617
CEMPRA, INC. (Filer) CIK: 0001461993 (see all company filings)

IRS No.: 262644445 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35405 | Film No.: 121190948
SIC: 2834 Pharmaceutical Preparations